Market Quotes

5311 items in section

Oil Prices Slide Toward $70 Mark as Strait of Hormuz Traffic Resumes

Oil tankers are flowing through the Strait of Hormuz without disruption, cooling regional tensions that briefly spiked on Thursday. The renewed stability in the critical waterway has sent global crude benchmarks tumbling, putting the front-month U.S. contract on track to settle below $70 per barrel for the first time since March.

FactSet Shares Jump as AI Portfolio Analytics Reach Buy-Side Clients

Investors pushed FactSet Research Systems shares up 10% on Friday to $229.50, reacting to the financial data firm's integration of portfolio analytics into its AI-driven model context protocol. The expansion aims to streamline how buy-side professionals interact with complex risk and performance data through conversational interfaces.

Veon Partners With Ukraine to Develop AI Infrastructure

Kyivstar’s parent company, Veon, has signed a memorandum of understanding with the Ukrainian Ministry of Economy to construct a dedicated artificial-intelligence data center. This collaboration marks a strategic push to bolster the nation's technological sovereignty while integrating advanced computing power into its war-time digital economy.

Home Bancorp Splits Leadership Roles in Succession Push

Darren Guidry will take the helm as president of Home Bancorp starting July 1, a move that allows John Bordelon to narrow his focus as chief executive. The shift marks a structural pivot for the parent company of Home Bank, aimed at delineating strategic oversight from day-to-day execution.

Opus Genetics Stock Surges Following Russell Index Inclusion

Shares of Opus Genetics climbed 9.9% to $4.09 during Friday morning trading after the biopharmaceutical firm secured a spot across three major benchmarks. The company will join the Russell 3000, Russell 2000, and Russell Microcap indexes, signaling a notable shift in its market profile ahead of the upcoming rebalancing.

Xunlei Launches $20 Million Share Buyback Program

Investors pushed Xunlei shares up 9% to $5.50 on Friday morning after the technology firm authorized a new $20 million repurchase program. The initiative, set to begin July 1, allows the company to buy back American Depositary Shares or common stock over the next 12 months using its existing cash reserves.

Omeros Shares Slump After EU Rejects Narsoplimab Approval

Shares of Omeros Corporation plunged 25% to $8 in premarket trading Friday after the European Medicines Agency delivered a negative opinion on the company’s lead drug, narsoplimab. The decision stalls the biotech firm’s efforts to introduce its treatment for a lethal post-transplant complication into the European market.

Christian Fischer to Succeed Stefan Hartung at Robert Bosch

After four years at the helm of the world's largest automotive supplier, Stefan Hartung is stepping down as chairman of Robert Bosch. The leadership transition, initiated at Hartung's own request, marks a pivotal shift for the German engineering giant as it navigates a rapidly evolving global manufacturing landscape.

i-80 Gold Terminates Legacy Offtake Deal to Capture Market Pricing

Nevada-focused miner i-80 Gold has scrapped a restrictive sales agreement with Vox Royalty, a strategic move intended to reclaim control over its production output. By eliminating a fixed-price delivery obligation for its Granite Creek and Ruby Hill properties, the company aims to capitalize on current market valuations rather than historical benchmarks.

Apogee Enterprises Shares Surge on Profit Turnaround

Shares of Apogee Enterprises climbed 12% to $47.60 in premarket trading after the architectural products manufacturer reported a sharp shift to profitability. Despite a slight dip in quarterly revenue, the company’s aggressive cost-cutting measures successfully propelled its bottom line out of the previous year’s red ink.

Acadia Pharmaceuticals Surges on European Approval Milestone

Shares of Acadia Pharmaceuticals climbed 13% to $27.30 in premarket trading Friday, reacting to a favorable recommendation from the European Medicines Agency for its Rett syndrome treatment, Daybu. The decision marks a critical step toward securing marketing authorization for the neurodevelopmental drug across the European Union.

Raytheon Secures $1.1 Billion Navy Deal for AIM-9X Missiles

A $1.1 billion contract from the U.S. Navy will see Raytheon ramp up production of its AIM-9X Block II missiles. The agreement, announced Friday, aims to replenish domestic stockpiles while addressing a surge in procurement requests from allied nations looking to modernize their infrared-tracking capabilities.

UFC South Lawn Fight Sets Record for TKO Group

The cage match staged on the White House South Lawn this June drew an estimated 34 million global viewers, marking the highest domestic viewership in the history of the Ultimate Fighting Championship. TKO Group confirmed the numbers following a complex aggregation of international broadcast data finalized weeks after the event.

Mexico Records Third Consecutive Monthly Trade Surplus

Driven by a robust 25.4% surge in exports, Mexico secured a $2.26 billion trade surplus in May. This performance marks the third straight month of positive trade balance, as the country’s export growth successfully outpaced a 24% rise in import spending, according to data released by the national statistics institute Inegi.

Erdene Resource Development Launches Share Buyback After Stock Slump

With its stock price down 40% since the beginning of 2026, Erdene Resource Development is moving to stabilize its market position. The Canadian firm secured approval from the Toronto Stock Exchange to initiate a normal course issuer bid, targeting the repurchase of up to 4.9 million shares for cancellation.

Corus Entertainment Losses Deepen Amid Advertising Slump

A 16% revenue slide has pushed Corus Entertainment into a deeper financial hole, with the Canadian media giant reporting a quarterly loss of C$36.5 million. The company continues to struggle against a persistent decline in television advertising, leaving earnings well short of market expectations for the period ending May 31.

Bunker Hill Mining Gains Ground in Idaho Water Dispute

A federal court in Idaho has dismantled the core of Crescent Mine's litigation against Bunker Hill Mining, dismissing central claims under the Comprehensive Environmental Response, Compensation, and Liability Act. The ruling effectively halts Crescent’s bid to force a mine drainage mandate, shifting the legal momentum back to Bunker Hill.

Elroy Air Targets Nasdaq Listing in $1 Billion SPAC Merger

Autonomous heavy-cargo drone developer Elroy Air is moving toward a public listing through a merger with Columbus Circle Capital. The blank-check firm confirmed the deal on Friday, setting the stage for the aviation startup to transition from specialized prototype development to large-scale commercial manufacturing by the end of the year.

PowerBank Secures First U.S. Federal Contract for Defense Site

A $2.95 million federal contract will see Toronto-based PowerBank install a solar-powered canopy and electric-vehicle charging infrastructure at the Armed Forces Reserve Center in Farmingdale, New York. The project marks the solar and battery storage firm’s first direct engagement with the U.S. Department of Defense and the Department of the Army.

Fortrea Holdings Names Jason Knoblauch as New CFO

Jill McConnell is stepping down as chief financial officer of Fortrea Holdings, marking a leadership transition for the contract-research organization. The company confirmed that McConnell will remain through a transition period, while the search for her replacement has concluded with the appointment of an industry veteran.

Incyte’s Opzelura Nears EU Approval for Eczema Treatment

The European Medicines Agency has issued a positive recommendation for Opzelura, Incyte’s topical cream intended to treat moderate atopic dermatitis. Should the European Commission follow this guidance, the product would become the first steroid-free topical therapy available in the European Union for patients who have not responded to standard treatments.

Eli Lilly Wins European Backing for Leukemia Treatment Jaypirca

European regulators have issued a positive opinion recommending Jaypirca as a primary treatment for chronic lymphocytic leukemia, marking a significant step toward broader market availability for Eli Lilly. The decision follows a review of clinical data indicating the drug provides consistent efficacy across all lines of therapy.

Mattr Clears Regulatory Hurdle for 3.6 Million Share Buyback

With shares surging nearly 58% throughout 2026, Mattr has secured approval from the Toronto Stock Exchange to initiate a fresh buyback program. The materials technology firm plans to repurchase up to 10% of its outstanding stock, targeting 3.6 million shares for cancellation starting at the end of June.

Lululemon Expands Board Following Settlement With Founder Chip Wilson

Chip Wilson’s long-standing public campaign against Lululemon’s leadership has reached a resolution, with the retailer appointing two new board directors. The move, which expands the board from nine to 11 members, follows an agreement designed to avert a potential proxy fight that threatened the company’s governance stability.

Titan Mining Stock Jumps 39% on U.S. Army Graphite Deal

A 39% premarket surge pushed Titan Mining shares to $3.10 on Friday, reversing a 25% year-to-date slide after the company secured long-term leases from the U.S. Army. The agreement grants the miner space at two Alabama military bases to construct a domestic facility for purifying graphite, a critical battery material.

Sinda Sets IPO Price at $12 Per Share

Sinda is hitting the public market with a valuation anchored at $12 a share, signaling a pivotal expansion for the silver-mining firm. The company confirmed late Thursday that it intends to offload approximately 17.8 million shares, with underwriters holding a 30-day window to acquire an additional 2.66 million units.

S.Science Co. Losses Deepen to 2.53 Billion Yen

Tokyo-based S.Science Co. Ltd. reported a significant widening of its financial losses for the fiscal year ending March 31, 2026, with net losses surging to 2.53 billion yen. This marks a sharp decline from the 96 million yen loss recorded during the previous fiscal year, despite a notable increase in annual revenue.

TotalEnergies Employees Invest 310 Million Euros in Capital Increase

More than 59,000 TotalEnergies employees across 97 countries have purchased company shares, committing 310.5 million euros in the latest capital increase. The move pushes employee ownership to approximately 7.6% of the energy giant’s total share capital, signaling strong internal support for the firm's long-term strategic direction.

Naito & Co. Profits Quadruple in Strong First Quarter

Naito & Co. reported a sharp surge in profitability for the first quarter ending May 31, with net profit reaching 235 million yen compared to 53 million yen during the same period last year. The results reflect significant gains across the company's financial metrics under Japanese accounting standards.

Techno Horizon Swings to Profit as Revenue Climbs

Techno Horizon Co. Ltd. recorded a net profit of 2.46 billion yen for the fiscal year ending March 31, marking a sharp reversal from the 616 million yen loss reported the previous year. The Japanese firm’s financial turnaround was driven by steady top-line growth and a significant expansion in operating margins.